I could eat my words here, but I really don't think ozempic is relevant here. It hasn't been shown to reduce ICP and presendin hasn't been shown to aid in weight loss. The issue in my opinion is lumbar puncture and the prospect of being on a placebo for 24 weeks. Coupled with the currently rigorous diagnostic criteria to admit patients as I said a few days ago. If management decides to half the trial size and admit a wider variety of patients *hopefully* it will still show efficacy
- Forums
- ASX - By Stock
- Ann: Phase III Clinical Trial Update and New IIH Market Analysis
I could eat my words here, but I really don't think ozempic is...
-
-
- There are more pages in this discussion • 116 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
RCE
Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
LU7
The Breakdown: Lithium Universe talks refinery design and lithium processing in strong preliminary feasibility study for Bécancour
Add IXC (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.6¢ |
Change
0.005(6.17%) |
Mkt cap ! $6.463M |
Open | High | Low | Value | Volume |
8.1¢ | 8.6¢ | 8.1¢ | $9.821K | 117.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 125000 | 8.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.6¢ | 8450 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 125000 | 0.080 |
1 | 84879 | 0.076 |
1 | 6693 | 0.075 |
1 | 500000 | 0.040 |
1 | 70001 | 0.036 |
Price($) | Vol. | No. |
---|---|---|
0.086 | 8450 | 1 |
0.095 | 100000 | 1 |
0.100 | 2750 | 1 |
0.150 | 713 | 1 |
0.000 | 0 | 0 |
Last trade - 15.47pm 10/10/2024 (20 minute delay) ? |
Featured News
IXC (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online